ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
九源基因
6.090
+0.000
手動刷新
成交量:
5.54萬
成交額:
33.71萬
市值:
14.92億
市盈率:
8.35
高:
6.100
開:
6.090
低:
6.040
收:
6.090
資料載入中...
總覽
公司
新聞資訊
公告
九源基因03月06日主力淨流入51萬元 散户資金拋售
市场透视
·
03-06
九源基因02月26日遭主力拋售18萬元
市场透视
·
02-26
九源基因02月20日獲主力加倉27萬元
市场透视
·
02-20
九源基因擬更名為“杭州九源基因生物醫藥股份有限公司”
新浪港股
·
02-13
九源基因(02566.HK)建議更改公司名稱
阿斯达克财经
·
02-13
九源基因(02566)擬更名為“杭州九源基因生物醫藥股份有限公司”
智通财经
·
02-12
九源基因(02566)股價上升6.724%,現價港幣$6.19
阿斯达克财经
·
02-07
九源基因(02566.HK)1月24日收盤上漲3.1%,成交52.14萬港元
金融界
·
01-24
九源基因1月22日收盤下跌1.44%,成交57.05萬港元
金融界
·
01-22
九源基因:聚乙二醇化藥物獲批上市
和讯网
·
01-21
九源基因(02566.HK)吉新芬獲國家藥監局批准上市
阿斯达克财经
·
01-21
九源基因(02566):吉新芬®獲國家藥品監督管理局批准上市
智通财经
·
01-20
九源基因(02566)股價上升5.254%,現價港幣$5.81
阿斯达克财经
·
01-20
九源基因(02566)股價下跌5.445%,現價港幣$5.21
阿斯达克财经
·
01-15
九源基因1月10日收盤下跌7.04%,成交395.35萬港元
金融界
·
01-10
九源基因盤中最低價觸及5.400港元,創近一年新低
金融界
·
01-10
九源基因1月6日收盤下跌0.32%,成交86.1萬港元
金融界
·
01-06
首個國產司美格魯肽上市申請暫未獲批,但GLP-1賽道已向紅海
国际金融报
·
01-02
港股異動 | 九源基因(02566)尾盤跌近6%再創新低 較招股價已腰斬 司美格魯肽上市申請未獲批准
智通财经
·
01-02
華東醫藥注射用肉毒毒素上市許可申請獲受理 未和九源基因商業化合作
深圳商报·读创
·
01-02
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02566/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02566","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02566\",,,,,undefined,":{"symbol":"02566","market":"HK","secType":"STK","nameCN":"九源基因","latestPrice":6.09,"timestamp":1746778087016,"preClose":6.09,"halted":0,"volume":55400,"delay":0,"floatShares":109000000,"shares":245000000,"eps":0.7291073809653457,"marketStatus":"休市中","change":0,"latestTime":"05-09 16:08:07","open":6.09,"high":6.1,"low":6.04,"amount":337102,"amplitude":0.009852,"askPrice":6.09,"askSize":59000,"bidPrice":6.02,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":0.7291073809653457,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1747013400000},"marketStatusCode":7,"adr":0,"listingDate":1732723200000,"exchange":"SEHK","adjPreClose":6.09,"dividendRate":0.009788,"openAndCloseTimeList":[[1746754200000,1746763200000],[1746766800000,1746777600000]],"volumeRatio":0.9578146626245387,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02566\",,,,,undefined,":{"symbol":"02566","floatShares":109000000,"roa":"6.08%","roe":"11.47%","lyrEps":0.729107,"volumeRatio":0.9578146626245387,"shares":245000000,"dividePrice":0.060163,"high":6.1,"amplitude":0.009852,"preClose":6.09,"low":6.04,"week52Low":5.18,"pbRate":"0.91","psRate":"1.01","week52High":9.1,"institutionHeld":0,"latestPrice":6.09,"committee":-0.966667,"eps":0.7291073809653457,"divideRate":0.009788,"volume":55400,"delay":0,"ttmEps":0.7291073809653457,"open":6.09,"prevYearClose":6.6,"prevWeekClose":5.98,"prevMonthClose":5.95,"prevQuarterClose":6.78,"fiveDayClose":5.95,"twentyDayClose":5.59,"sixtyDayClose":6.3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02566\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517136013","title":"九源基因03月06日主力淨流入51萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2517136013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517136013?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 16:15","pubTimestamp":1741248959,"startTime":"0","endTime":"0","summary":"03月06日, 九源基因股价涨1.68%,报收6.64元,成交金额172万元,换手率0.24%,振幅3.83%,量比1.17。九源基因今日主力资金净流入51万元,上一交易日主力净流出0万元。该股近5个交易日下跌5.14%,主力资金累计净流入31万元;近20日主力资金累计净流入134万元,其中净流入天数为8日。该股主力净额占比0.07%,港股市场排名171/2651。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306165519a2622928&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306165519a2622928&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2514886189","title":"九源基因02月26日遭主力拋售18萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514886189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514886189?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 16:17","pubTimestamp":1740557839,"startTime":"0","endTime":"0","summary":"02月26日, 九源基因股价跌0.43%,报收6.98元,成交金额144万元,换手率0.19%,振幅2.71%,量比0.52。九源基因今日主力资金净流出18万元,上一交易日主力净流出4万元。该股近5个交易日下跌1.13%,主力资金累计净流入41万元;近20日主力资金累计净流入93万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226165106abdd9447&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226165106abdd9447&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2512410418","title":"九源基因02月20日獲主力加倉27萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512410418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512410418?lang=zh_tw&edition=fundamental","pubTime":"2025-02-20 16:15","pubTimestamp":1740039311,"startTime":"0","endTime":"0","summary":"02月20日, 九源基因股价涨0.14%,报收7.07元,成交金额196万元,换手率0.26%,振幅3.12%,量比0.47。九源基因今日主力资金净流入27万元,上一交易日主力净流入2万元。该股近5个交易日上涨14.96%,主力资金累计净流入43万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出39万元,其中净流出天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220161527abd5ddd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220161527abd5ddd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2511537098","title":"九源基因擬更名為“杭州九源基因生物醫藥股份有限公司”","url":"https://stock-news.laohu8.com/highlight/detail?id=2511537098","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511537098?lang=zh_tw&edition=fundamental","pubTime":"2025-02-13 08:06","pubTimestamp":1739405160,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 九源基因(02566)公布,董事会已议决建议将公司的中文名称由“杭州九源基因工程股份有限公司”更改为“杭州九源基因生物医药股份有限公司”,及将公司的英文名称由“Hangzhou Jiuyuan Gene Engineering Co.,Ltd.”更改为“Hangzhou Jiuyuan Genetic Biopharmaceutical Co.,Ltd.”\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-02-13/doc-inekhuek1010530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02566","161726","399441"],"gpt_icon":0},{"id":"2511355853","title":"九源基因(02566.HK)建議更改公司名稱","url":"https://stock-news.laohu8.com/highlight/detail?id=2511355853","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511355853?lang=zh_tw&edition=fundamental","pubTime":"2025-02-13 08:06","pubTimestamp":1739405160,"startTime":"0","endTime":"0","summary":"九源基因(02566.HK) 公布,其已议决建议将公司的中文名称由“杭州九源基因工程股份有限公司”更改为“杭州九源基因生物医药股份有限公司”,以及将公司的英文名称由“Hangzhou Jiuyuan Gene Engineering Co., Ltd.”更改为“Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.”。九源基因解释,建议更改公司名称旨在全面地反映公司的行业定位,以及准确地反映公司的未来战略发展方向。(js/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20241126155522559_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20241126155522559_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1416870/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02566"],"gpt_icon":0},{"id":"2510308228","title":"九源基因(02566)擬更名為“杭州九源基因生物醫藥股份有限公司”","url":"https://stock-news.laohu8.com/highlight/detail?id=2510308228","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510308228?lang=zh_tw&edition=fundamental","pubTime":"2025-02-12 22:46","pubTimestamp":1739371616,"startTime":"0","endTime":"0","summary":"智通财经APP讯,九源基因(02566)公布,董事会已议决建议将公司的中文名称由“杭州九源基因工程股份有限公司”更改为“杭州九源基因生物医药股份有限公司”,及将公司的英文名称由“Hangzhou Jiuyuan Gene Engineering Co.,Ltd.”更改为“Hangzhou Jiuyuan Genetic Biopharmaceutical Co.,Ltd.”","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1249111.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161726","399441","02566"],"gpt_icon":0},{"id":"2509678897","title":"九源基因(02566)股價上升6.724%,現價港幣$6.19","url":"https://stock-news.laohu8.com/highlight/detail?id=2509678897","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509678897?lang=zh_tw&edition=fundamental","pubTime":"2025-02-07 14:48","pubTimestamp":1738910880,"startTime":"0","endTime":"0","summary":"[上升股]九源基因(02566) 股价在下午02:48比前收市价上升6.724%,现股价为港币$6.19。至目前为止,今日最高价为$6.19,而最低价为$5.7。总成交量为21万股,总成交金额为港币$122.886万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2502074530/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02566"],"gpt_icon":0},{"id":"2505807128","title":"九源基因(02566.HK)1月24日收盤上漲3.1%,成交52.14萬港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505807128","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505807128?lang=zh_tw&edition=fundamental","pubTime":"2025-01-24 16:26","pubTimestamp":1737707198,"startTime":"0","endTime":"0","summary":"1月24日,截至港股收盘,恒生指数上涨1.86%,报20066.19点。九源基因收报5.65港元/股,上涨3.1%,成交量9.3万股,成交额52.14万港元,振幅4.2%。最近一个月来,九源基因累计跌幅19.77%,今年来累计跌幅16.97%,跑输恒生指数-1.79%的跌幅。财务数据显示,截至2024年6月30日,九源基因实现营业总收入7.02亿元,同比增长5.87%;归母净利润1.05亿元,同比增长9.33%;毛利率76.96%,资产负债率29.96%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/24162647787599.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02566"],"gpt_icon":0},{"id":"2505713634","title":"九源基因1月22日收盤下跌1.44%,成交57.05萬港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505713634","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505713634?lang=zh_tw&edition=fundamental","pubTime":"2025-01-22 16:59","pubTimestamp":1737536379,"startTime":"0","endTime":"0","summary":"1月22日,截至港股收盘,恒生指数下跌1.63%,报19778.77点。九源基因收报5.49港元/股,下跌1.44%,成交量10.26万股,成交额57.05万港元,振幅3.05%。最近一个月来,九源基因累计跌幅19.5%,今年来累计跌幅16.82%,跑输恒生指数-1.4%的跌幅。财务数据显示,截至2024年6月30日,九源基因实现营业总收入7.02亿元,同比增长5.87%;归母净利润1.05亿元,同比增长9.33%;毛利率76.96%,资产负债率29.96%。机构评级方面,目前暂无机构对该股做出投资评级建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122170407986f2781&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122170407986f2781&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2505959132","title":"九源基因:聚乙二醇化藥物獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2505959132","media":"和讯网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505959132?lang=zh_tw&edition=fundamental","pubTime":"2025-01-21 09:33","pubTimestamp":1737423225,"startTime":"0","endTime":"0","summary":"【九源基因:聚乙二醇化人粒细胞刺激因子注射液获批上市】九源基因公布,其聚乙二醇化人粒细胞刺激因子注射液已获国家药品监督管理局批准上市。该注射液用于治疗成年非髓性恶性肿瘤患者,可降低相关感染发生率。其由人粒细胞刺激因子与 20KD 聚乙二醇交联并经纯化获得,具有诸多优点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121103708986d7c8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121103708986d7c8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2505233999","title":"九源基因(02566.HK)吉新芬獲國家藥監局批准上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2505233999","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505233999?lang=zh_tw&edition=fundamental","pubTime":"2025-01-21 01:12","pubTimestamp":1737393120,"startTime":"0","endTime":"0","summary":"九源基因(02566.HK) 公布,聚乙二醇化人粒细胞刺激因子注射液(商标名︰吉新芬)已获中国国家药监局批准上市,用于治疗成年非髓性恶性肿瘤患者在接受易引起发热性中性粒细胞减少症的骨髓抑制性抗癌药物治疗时,降低以发热性中性粒细胞减 少症为表现的感染发生率。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20241126155526856_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20241126155526856_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1411882/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02566"],"gpt_icon":0},{"id":"2504240227","title":"九源基因(02566):吉新芬®獲國家藥品監督管理局批准上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2504240227","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504240227?lang=zh_tw&edition=fundamental","pubTime":"2025-01-20 20:56","pubTimestamp":1737377798,"startTime":"0","endTime":"0","summary":"智通财经APP讯,九源基因(02566)公布,聚乙二醇化人粒细胞刺激因子注射液(商标名:吉新芬®)已获中华人民共和国国家药品监督管理局批准上市,用于治疗成年非髓性恶性肿瘤患者在接受易引起发热性中性粒细胞减少症的骨髓抑制性抗癌药物治疗时,降低以发热性中性粒细胞减少症为表现的感染发生率。吉新芬®由人粒细胞刺激因子(hG-CSF)与20KD聚乙二醇交联并经纯化获得,半衰期明显延长,生物稳定性增强,不易被酶解,免疫原性与抗原性降低,不易产生中和性抗体。聚乙二醇化人粒细胞刺激因子(PEG-hG-CSF)一个化疗周期仅需一次给药,提高患者依从性,有效保障患者安全及化疗方案足剂量足疗程实施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1240704.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02566"],"gpt_icon":0},{"id":"2504644540","title":"九源基因(02566)股價上升5.254%,現價港幣$5.81","url":"https://stock-news.laohu8.com/highlight/detail?id=2504644540","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504644540?lang=zh_tw&edition=fundamental","pubTime":"2025-01-20 10:30","pubTimestamp":1737340200,"startTime":"0","endTime":"0","summary":"[上升股]九源基因(02566) 股价在上午10:30比前收市价上升5.254%,现股价为港币$5.81。至目前为止,今日最高价为$5.81,而最低价为$5.54。总成交量为1.92万股,总成交金额为港币$10.875万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2501203437/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02566"],"gpt_icon":0},{"id":"2503695387","title":"九源基因(02566)股價下跌5.445%,現價港幣$5.21","url":"https://stock-news.laohu8.com/highlight/detail?id=2503695387","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503695387?lang=zh_tw&edition=fundamental","pubTime":"2025-01-15 15:45","pubTimestamp":1736927100,"startTime":"0","endTime":"0","summary":"[下跌股]九源基因(02566) 股价在下午03:45比前收市价下跌5.445%,现股价为港币$5.21。至目前为止,今日最高价为$5.51,而最低价为$5.21。总成交量为11.96万股,总成交金额为港币$63.78万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD250115807/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02566"],"gpt_icon":0},{"id":"2502367896","title":"九源基因1月10日收盤下跌7.04%,成交395.35萬港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502367896","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502367896?lang=zh_tw&edition=fundamental","pubTime":"2025-01-10 17:20","pubTimestamp":1736500852,"startTime":"0","endTime":"0","summary":"1月10日,截至港股收盘,恒生指数下跌0.92%,报19064.29点。九源基因收报5.41港元/股,下跌7.04%,成交量71.62万股,成交额395.35万港元,振幅7.22%。最近一个月来,九源基因累计跌幅26.99%,今年来累计跌幅18.03%,跑输恒生指数-4.96%的跌幅。财务数据显示,截至2024年6月30日,九源基因实现营业总收入7.02亿元,同比增长5.87%;归母净利润1.05亿元,同比增长9.33%;毛利率76.96%,资产负债率29.96%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011017231395ff1449&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011017231395ff1449&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2502131899","title":"九源基因盤中最低價觸及5.400港元,創近一年新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2502131899","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502131899?lang=zh_tw&edition=fundamental","pubTime":"2025-01-10 16:34","pubTimestamp":1736498083,"startTime":"0","endTime":"0","summary":"截至1月10日收盘,九源基因报5.410港元,较上个交易日下跌7.04%,当日盘中最低价触及5.400港元,创近一年新低。资金流向方面,当日主力流入89.917万港元,流出262.296万港元,净流出172.38万港元。杭州九源基因工程股份有限公司于1993年创立,是一家总部设于浙江省的中国生物制药公司,拥有逾30年生物药品及医疗器械研发、生产及商业化经验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011016380095ff056d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011016380095ff056d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2501002944","title":"九源基因1月6日收盤下跌0.32%,成交86.1萬港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501002944","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501002944?lang=zh_tw&edition=fundamental","pubTime":"2025-01-06 16:53","pubTimestamp":1736153622,"startTime":"0","endTime":"0","summary":"1月6日,截至港股收盘,恒生指数下跌0.36%,报19688.29点。九源基因收报6.2港元/股,下跌0.32%,成交量13.9万股,成交额86.1万港元,振幅4.02%。最近一个月来,九源基因累计跌幅24.51%,今年来累计跌幅5.76%,跑输恒生指数-1.49%的跌幅。财务数据显示,截至2024年6月30日,九源基因实现营业总收入7.02亿元,同比增长5.87%;归母净利润1.05亿元,同比增长9.33%;毛利率76.96%,资产负债率29.96%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106165738985c9283&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106165738985c9283&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2500949505","title":"首個國產司美格魯肽上市申請暫未獲批,但GLP-1賽道已向紅海","url":"https://stock-news.laohu8.com/highlight/detail?id=2500949505","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500949505?lang=zh_tw&edition=fundamental","pubTime":"2025-01-02 18:27","pubTimestamp":1735813631,"startTime":"0","endTime":"0","summary":"2024年12月31日,国家药品监督管理局的药品通知件送达信息显示,九源基因旗下司美格鲁肽注射液在列。这意味着该产品上市申请暂未获批准。首个国产司美格鲁肽暂未获批司美格鲁肽是一款GLP-1受体激动剂,原研药厂商为丹麦制药企业诺和诺德。国内方面,翰宇药业、正大天晴、通化东宝等旗下GLP-1类药物均已获批。除九源基因外,丽珠集团也已在2024年6月递交了司美格鲁肽注射液的上市申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102183335ab9bb064&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102183335ab9bb064&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566","BK1141","BK1576","03347","BK1583"],"gpt_icon":0},{"id":"2500198559","title":"港股異動 | 九源基因(02566)尾盤跌近6%再創新低 較招股價已腰斬 司美格魯肽上市申請未獲批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2500198559","media":"智通财经","labels":["policyRegulatory","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500198559?lang=zh_tw&edition=fundamental","pubTime":"2025-01-02 15:57","pubTimestamp":1735804653,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,九源基因尾盘跌近6%,低见6.22港元再创上市新低,较招股价12.42港元已腰斩。截至发稿,跌5.61%,报6.23港元,成交额368.43万港元。消息面上,据界面报道,国家药监局12月31日药品通知件送达信息显示:九源基因的司美格鲁肽注射液在列,意味着该产品暂时未获批准。今年4月2日,九源基因递交了司美格鲁肽注射液的上市申请并获受理,这也是国内第一家申报上市的司美格鲁肽生物类似药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1232398.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"港股异动 | 九源基因(02566)尾盘跌近6%再创新低 较招股价已腰斩 司美格鲁肽上市申请未获批准","news_tag":"policyRegulatory,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02566"],"gpt_icon":0},{"id":"2500013913","title":"華東醫藥注射用肉毒毒素上市許可申請獲受理 未和九源基因商業化合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2500013913","media":"深圳商报·读创","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500013913?lang=zh_tw&edition=fundamental","pubTime":"2025-01-02 15:16","pubTimestamp":1735802165,"startTime":"0","endTime":"0","summary":"华东医药(000963.SZ)1月2日发布公告,2024年12月31日,公司独家经销产品注射用重组A型肉毒毒素(研发代码:YY001)用于改善中度至重度眉间纹的上市许可申请获国家药品监督管理局受理。据悉,YY001是全球首款且目前唯一已递交上市申请的重组A型肉毒毒素产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202501023285461277.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02566"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":94,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02566\",params:#limit:5,,,undefined,":[{"date":"2025-06-13","symbol":"02566","amount":0.056,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-06-16","defaultRemindTime":1749778200000,"name":"九源基因","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-30","payableDate":"2025-06-16","currency":"CNY","dateTimestamp":1749744000000,"payDate":"2025-07-30"},{"date":"2025-03-26","symbol":"02566","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"","dateTimestamp":1742918400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02566\",market:\"HK\",,,undefined,":[{"executeDate":"2025-06-13","recordDate":"2025-06-16","paymentDate":"2025-07-30","value":0.056,"currency":"CNY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02566\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02566\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02566","date":"2025-05-08","current":10.406872,"percent":0.352941,"low":9.307514,"twenty":10.058598,"median":11.208381,"eighty":12.478117,"high":14.699674,"avg":11.385796,"sd":1.310589,"marketCap":1494478692},"quantilePoints":[{"date":"2024-12-06","current":14.097915,"twenty":14.208262,"median":14.275695,"eighty":14.595644,"marketCap":1946012484},{"date":"2024-12-13","current":13.217326,"twenty":13.348436,"median":13.95821,"eighty":14.334483,"marketCap":1820859096},{"date":"2024-12-20","current":12.20261,"twenty":12.40882,"median":13.381214,"eighty":14.243818,"marketCap":1673619816},{"date":"2024-12-27","current":12.158366,"twenty":12.254449,"median":13.1954,"eighty":14.180675,"marketCap":1666257852},{"date":"2025-01-03","current":11.126814,"twenty":12.0799,"median":12.46117,"eighty":14.042033,"marketCap":1526380536},{"date":"2025-01-10","current":9.714633,"twenty":11.141125,"median":12.29741,"eighty":13.763077,"marketCap":1327607508},{"date":"2025-01-17","current":9.904165,"twenty":10.518129,"median":12.180488,"eighty":13.509332,"marketCap":1354601376},{"date":"2025-01-24","current":10.07429,"twenty":9.9409,"median":12.04207,"eighty":13.348436,"marketCap":1386503220},{"date":"2025-01-28","current":10.358786,"twenty":9.995541,"median":11.819979,"eighty":13.282881,"marketCap":1433128992},{"date":"2025-02-07","current":11.238302,"twenty":10.0243,"median":11.162591,"eighty":13.191014,"marketCap":1546012440},{"date":"2025-02-14","current":11.154484,"twenty":10.062805,"median":11.126814,"eighty":12.776093,"marketCap":1533742500},{"date":"2025-02-21","current":12.73316,"twenty":10.073062,"median":11.193598,"eighty":12.735779,"marketCap":1757055408},{"date":"2025-02-28","current":11.508443,"twenty":10.189099,"median":11.508443,"eighty":12.653552,"marketCap":1582822260},{"date":"2025-03-07","current":12.084413,"twenty":10.276651,"median":11.554796,"eighty":12.584056,"marketCap":1668711840},{"date":"2025-03-14","current":12.91496,"twenty":10.28916,"median":11.611229,"eighty":12.584056,"marketCap":1784049276},{"date":"2025-03-21","current":12.244709,"twenty":10.311241,"median":11.810026,"eighty":12.735779,"marketCap":1690797732},{"date":"2025-03-28","current":11.696332,"twenty":10.344738,"median":11.831112,"eighty":12.72799,"marketCap":1734969516},{"date":"2025-04-03","current":10.807781,"twenty":10.395616,"median":11.800074,"eighty":12.674918,"marketCap":1600000176},{"date":"2025-04-11","current":9.828764,"twenty":10.27298,"median":11.65378,"eighty":12.589531,"marketCap":1445398932},{"date":"2025-04-17","current":9.988361,"twenty":10.075173,"median":11.569961,"eighty":12.56072,"marketCap":1472392800},{"date":"2025-04-25","current":10.079541,"twenty":10.050182,"median":11.463659,"eighty":12.511173,"marketCap":1487116728},{"date":"2025-05-02","current":10.290636,"twenty":10.067013,"median":11.287756,"eighty":12.494061,"marketCap":1467484824},{"date":"2025-05-08","current":10.406872,"twenty":10.058598,"median":11.208381,"eighty":12.478117,"marketCap":1494478692}],"updateTime":1746803884652}}}